Cardiac Imaging to Detect Cardiotoxicity From Proteasome Inhibitors With a View to the ESC Guidelines

Prof Daniel Lenihan is a cardio-oncologist specialising in cardiology, heart disease and advanced heart failure, at Saint Francis Healthcare System, Cape Girardeau, US.

He is a co-Founder and Board Member of the International Cardio-Oncology Society (ICOS), which is an international professional association whose primary goal is to eliminate cardiac disease as a barrier to effective cancer therapy. 

He is actively involved in patient care as the Director of the Cardio-Oncology Programme, Cardiac Rehabilitation, and the Heart Failure clinic at Saint Francis Healthcare System.

Dr Marielle Scherrer-Crosbie is the Director of the Echocardiography Laboratory at the Hospital of the University of Pennsylvania, Philadelphia, Philadelphia, US. Her main research interests are in the use of imaging and biomarkers in cardio-oncology both in human populations and in small animal models. She also uses small animal models in studying subclinical cardiac dysfunction in metabolic abnormalities.

Prof Teresa López Fernández is a clinical investigator and consultant cardiologist at La Paz University Hospital in Madrid, ES. She specialises in cardiac imaging (she is board certified in advanced and transesophageal echocardiography by the European Society of Cardiology (ESC)) and cardio-oncology (she is board certified by the International Cardio-Oncology Society), and currently coordinates the cardio-oncology team at La Paz University Hospital. She is the founder and chair of the Spanish Cardio-Oncology Working Group at the Spanish Society of Cardiology (SEC) and the Secretary of the ESC Council of Cardio-Oncology.

Michaela Liedtke, is an Associate Professor of Medicine at the Stanford University School of Medicine, Stanford, US where she also serves as the Medical Director of the Leukemia inpatient service, Co-Director of the Stanford Adolescent and Young Adult Cancer program, and Co-Director of the Stanford Amyloid Center. 

She specialises in research and treatment of multiple myeloma/amyloidosis and acute lymphoblastic leukemia, with particular interest in adolescents and young adults and CAR-T cell technology, and has contributed to numerous clinical and translational studies in her field.

Dr Liedtke is an active member of the American Society of Hematology and the American Society of Clinical Oncology, serves on the Leukemia committee for the Southwest Oncology Group, and is a member of the NCCN Multiple Myeloma and AL amyloidosis Panel.

Dr Alexander is an advanced heart failure-trained cardiologist. He is also an Assistant Professor of Cardiovascular Medicine at Stanford University School of Medicine, Stanford, US.

Dr Alexander specialises in the management of advanced heart failure and transplant cases, seeing a wide range of patients. He also has an active research laboratory, studying various forms of heart failure.

Dr Alexander has expertise in diagnosing and treating transthyretin cardiac amyloidosis, a critical yet underdiagnosed cause of heart failure among African Americans and the elderly. He is conducting extensive research to enhance our understanding of this condition, with grant support from the National Institutes of Health and American Heart Association, among other sources.

Prof Joe Carver is the Bernard Fishman Clinical Professor of Medicine at the Abramson Cancer Center of the University of Pennsylvania, Philadelphia, US. He is the Chief of Staff at the Abramson Cancer Center.

He is the Director of the Thalheimer Cardio-oncology Center at the Abramson Cancer Center and his clinical practice is in the subspecialty of cardio-oncology.